Description
Molecular characterisation of colorectal cancer by liquid biopsy based on the analysis of ctDNA and CTCs. Application of radiomics in prognostic assessment. Study of the mechanisms of resistance to standard and targeted therapy and identification of new therapeutic targets. Development of clinical trials with drugs directed against potentially targetable alterations.
Keywords
Oncology, colorectal cancer, phase I trials, candidate gene sequencing, mutation detection solid tumours, liquid biopsies
Frascati classification
